Marpai, Inc. (MRAI): Entry into a Material Definitive Agreement

Marpai, Inc. (MRAI) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Exhibit 99.1 Marpai Announces $12 Million Private Placement led by Mitchell Companies Tampa, Florida — July 29, 2026 — Marpai, Inc. (“Marpai” or the “Company”) (OTCQX: MRAI), a leader in innovative healthcare technology, Third-Party Administration (“TPA”), and Pharmacy Benefit Ma

Event · Offering · closed
Instrument
convertible preferred stock
Gross proceeds
$12 million
Shares
12,100 shares
Price per share
$1,000 per share

Facts are quoted from the filing text and checked against it.

Original reporting
Published Jul 31, 2026, 9:29 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jul 31, 2026, 9:31 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefCorporate actions
Primary signal
$MRAI
Neutral
medium confidence
Mentioned
$MRAI
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$MRAINeutralMed
01

Why it matters

This is a primary-source disclosure of a new equity raise framework, with stated minimum and maximum Preferred Stock proceeds ($2M to $5M). The market will focus on dilution mechanics and whether the deal closes on schedule.

02

Market read

A defined-range Series A Preferred Stock financing is disclosed, which can drive near-term repricing around dilution and capital runway expectations once full terms are reviewed.

03

What to watch

Traders will need the missing exhibits details (conversion price, discount, liquidation preference, investor rights, and closing conditions) to judge dilution and downside protection.

Relevance 6/10Novelty 6/10Timing: filed after-hours on 2026-07-31, for next-session trading review

Background

The 8-K reports Item 1.01 entry into a material definitive agreement and Item 3.02 unregistered sales of equity securities, referencing a Series A Securities Purchase Agreement dated July 29, 2026.

Company-level read

Ticker impact

$MRAINeutralMedium confidence
Context

Marpai, Inc. filed an 8-K disclosing entry into a Series A securities purchase agreement, including a $2M to $5M Preferred Stock sale range.

Expected impact

Near-term bias depends on pricing terms and investor participation, but dilution risk typically pressures the stock until details are digested.

Evidence & confidence

The excerpt confirms a material definitive agreement and an unregistered sale of equity securities, but it does not include the purchase price, conversion terms, or closing outcome, limiting precision on magnitude and direction.

Market effects

Adds another small-cap financing datapoint, but no sector-wide regulatory or competitive signal is disclosed in the excerpt.

No regional macro or cross-border impact is described.

No global market linkage is stated beyond standard securities-law language.

Counterpoint

If the Series A terms are favorable (e.g., limited dilution, strong investor quality, or non-dilutive structure), the financing could reduce liquidity risk and support the stock.

Key entities

  • Marpai, Inc.

    Delaware corporation filing the 8-K and entering the Series A securities purchase agreement.

  • Mitchell Family Trust II

    Identified as the Lead Investor in the agreement.

Related articles

$MRAIMed

Marpai Reports Second Quarter 2026 Financial Results

Marpai, Inc. (OTCQX: MRAI) reported Q2 2026 results for the three and six months ended June 30, 2026. Revenue fell to $8.6 million for six months ended June 30, 2026 from $10.1 million a year earlier. The company cited faster cost reductions improving gross margin, and amended debt maturities to 2028 and 2029. After quarter-end, it raised $12.1 million via a private placement.

$MRAIMedAI 8/10

Marpai Announces $12 Million Private Placement led by Mitchell Companies

Marpai, Inc. (OTCQX: MRAI) said it completed securities purchase agreements for a $12 million private placement of newly designated convertible preferred stock led by Mitchell Companies. The deal sold 12,100 shares at $1,000 each with a $1.00 initial conversion price. Preferred holders receive an 8% dividend in common shares and convert on a liquidity event or qualified public offering.

$MARAMed

MARA prices $185M debt offering after $1.1B Bitcoin sale

MARA priced an $185M debt offering at 8.75% interest, maturing in 2032, to finance its $1.5B acquisition of Long Ridge Energy. The deal includes a 485MW power plant and land for potential data centers. MARA recently sold $1.1B in Bitcoin to repay debt. Long Ridge generated $144M in annualized adjusted EBITDA, but interest payments may consume nearly half.

$RIOLow

Rio Tinto commits US$250m to address damage from Bougainville's Panguna mine

Rio Tinto will contribute $250m to a fund addressing environmental and human rights impacts of the Panguna mine, per an agreement with Bougainville Copper Limited, the Autonomous Bougainville Government, and community leaders. The fund aims to support practical responses to identified impacts and social projects. Details will be developed in consultation with communities.

$PLCEMed

The Children’s Place begins nationwide closing sales as the future of hundreds of stores remains uncertain

The Children's Place has begun nationwide closing sales across its 500 stores in the U.S. and Canada, following a Chapter 11 bankruptcy filing. The retailer is seeking a buyer to potentially preserve operations. Gymboree, also owned by the company, is included in the liquidation. Sales are ongoing in stores and online, with gift cards and rewards valid until Dec. 12, 2026. The company aims to complete the sale process by the end of December, but the future of stores and brands remains uncertain.